here is why budgenius and genius biotech corporation is

New Post Public Reply Private Reply Replies (0) Message Board
john1234
here is why budgenius and genius biotech corporation is importent to the marijuana industry. we have a testing lab and and a scientific web structure for doctors and patents plus recreational users to use. here is a article that will explain why this is importent to this industry.


Sabet: Big Tobacco was nothing compared to Big Marijuana

Proponents of legalization and other drug policy reforms make some important points. It is true that most people who try drugs do not get addicted - they stop after using a few times. It is also true - and regrettable - that America's incarceration rate is embarrassingly high and that blacks and Latinos bear the brunt of harsh arrest policies. And, finally, despite our best efforts, fully eradicating drug use and its consequences remains a distant dream.

But placing faith that legalization will help any of these issues is misguided. In fact, legalization threatens to further contribute to disproportionate health outcomes among minorities, all the while creating a massive new industry - Big Tobacco 2.0 - intent on addicting the most vulnerable in society.

For example, with much fanfare, and alongside the ex-president of Mexico, Vicente Fox, former head of Microsoft corporate strategy James Shivley announced this year that he was creating "the Starbucks of marijuana." His plan? To buy up marijuana stores in Colorado and Washington state, "mint(ing) more millionaires than Microsoft in this business." And so, in the midst of America's great debate about marijuana legalization, Big Marijuana is born. Pot legalization is no longer about a few friends calmly sharing a joint on the weekend in their own living room. Inevitably - and ever so swiftly - it has become about big business and big bucks.

Shivley isn't the only one preparing to cash in. At least three marijuana vending machine companies, already earning millions of dollars in revenue from medical marijuana "patients," have announced giant expansion plans. "It is like a gold rush," remarked one vending executive. A couple of Yale MBAs recently created a multimillion-dollar private equity firm dedicated solely to financing the marijuana business. As one of them explains, the firm has become inundated with pitches from businesses who plan to become the "Wal-Mart of marijuana." To a student of history, none of this should come as a surprise, of course. Tobacco executives in the 1900s wrote the playbook on the reckless and deceitful marketing of an addictive - and therefore hugely profitable - substance.

Indeed, Big Marijuana creates unique problems that neither the status quo (with all its deficiencies), nor a grow-your-own approach to legal marijuana presents. Like Big Tobacco, the large-scale commercialization of marijuana will require consistently high use rates and increasing addiction rates to keep shareholders and investors happy. We've seen this horror movie before.

First, we know that addictive industries generate the lion's share of their profits from addicts, not casual users. In the tobacco industry, 80 percent of the industry's profits come from 20 percent of smokers. So while most marijuana users try the drug and stop, or use very occasionally, and the brunt of the profits - and problems - come from the minority of users, that minority causes enormous problems to our roadways, educational system, workplace and health care system.

This means that creating addicts is the central goal. And - as every good tobacco executive knows (but won't tell you) - this, in turn, means targeting the young. People who start tobacco or marijuana in their youth, when their brains are still developing, have far greater chances of becoming addicted. Internal company memos released as a result of the great tobacco settlement tell us as much: "Less than one-third of smokers start after age 18," says one, and "if our company is to survive and prosper, we must get our share of the youth market. . (That) will require new brands tailored to the youth market." Such memos were circulated even as the tobacco industry was publicly rejecting youth cigarette use.

The poor and otherwise vulnerable are also prime targets. They suffer the highest addiction rates of any group. It's no wonder that peer-reviewed research has concluded that tobacco and liquor outlets are several times as likely to be in poorer communities of color, and that the tobacco industry has cozied up with homeless shelters and advocacy groups as part of its downscale marketing strategy.

David Goerlitz, a former Winston Man model who now suffers from smoking-related illnesses, testified before Congress in 1989: "Of course, children aren't the only targets. . Once, when I asked an R.J. Reynolds executive why he didn't smoke, he responded point-blank that 'We don't smoke this (expletive); we just sell it. We reserve that right for the young, the poor, the black and the stupid.'"

That doesn't mean we have to be content with the status quo. We need much better science-based prevention, early intervention and treatment. We need to make sure our laws are equitable and fair. Specifically, even as marijuana remains illegal, low-level marijuana offenses should not saddle people with a criminal record that hurts their chances at education, housing or other assistance. Drug treatment courts and smart probation programs must also be taken to scale.

But under legalization, big business and big lobbies peddle pseudoscience and stop at nothing to protect their profits. Before it was ordered to disband due to deceitful practices, Tobacco Institute Inc. was the industry's lobby group, challenging studies linking smoking with cancer and rebutting surgeon general reports on cigarettes before they were even published. Today, tobacco still has a powerful presence in Washington. It fights any safety measures that might curb cigarette use and ensures that federal cigarette taxes remain low. (To bring federal cigarette taxes back to their inflation-adjusted level in 1960, we'd have to see a 17 percent increase in tobacco taxes today.) We can fully expect marijuana profiteers to recycle the tactics that have earned Big Tobacco billions and billions of dollars.

Already, the claims made by Big Tobacco only a few decades ago are being revived by the new marijuana moguls: "Moderate marijuana use can be healthy." "Marijuana-laced candy is meant only for adults." "Smoked marijuana is medicine." It is true that marijuana is not as addictive as tobacco (in fact, tobacco is more addictive than even heroin). And marijuana and tobacco differ among other dimensions of harm. Tobacco, though deadly, is not psychoactive. And unlike marijuana, one can drive impairment-free while smoking tobacco. That means that when someone is high, their ability to learn, work and become an active member of society is threatened. That is the last thing young people need today as they try to get a quality job or education.

Indeed, education and public health professionals, including groups like the American Medical Association, National School Nurses Association, American Society of Addiction Medicine, American Psychiatric Association, American Pediatrics Association and American Lung Association, regard today's high-potency marijuana as harmful. The best science tells us that learning and IQ are directly affected by regular marijuana use among kids and that marijuana use is associated with a host of other problems such as mental illness, car crashes and increased health care costs.

Can we afford decades of deceit from an industry that depends on addiction and heavy use for profits all over again? Some say that it doesn't have to be this way. We could establish a safer form of legalization by setting up measures that prevent the emergence of another Big Tobacco. History and experience show, however, that even the best of intentions are easily mowed over in the name of big profits. This will be American-style legalization. Unless we repeal the First Amendment - which declares commercial speech as free speech - and unless we quickly do away with our long-standing Madison Avenue culture of hypercommercialization, legal marijuana will lead down an all-too-familiar path. We are seeing this play out in Colorado with abandon.

It will be the Yale MBAs, the established addictive industries and the new Mad Men of marijuana who will benefit most from legalization.

"Let's go big or go home," was Shivley's final remark to the press after his announcement about creating the Starbucks of marijuana. In order to avoid another public health disaster and give our young people a chance to succeed, let's hope that he and others like him do go home. But we shouldn't count on it.

Kevin Sabet, director of the Drug Policy Institute at the University of Florida, is the co-founder of Smart Approaches to Marijuana and served as senior adviser at the White House Office of National Drug Control Policy from 2009 to 2011.

reference to this article
http://www.newsday.com/opinion/oped/if-you-th...-1.9338064

Rightsmile Inc. (RIGH) Stock Research Links

RIGH Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASMAX Unleashes Next-Level Motorcycle Comms at EICMA

Updated Category News Views 124

Transforming the Motorcycle Communication Landscape Motorcycling ain't just about the roaring engines and the rubber on the road. In the world of helmets and handlebars, some bright minds are weaving tech magic at the EICMA 2026 in Milan. ASMAX has rolled out its shiny new RoamX intercom gadget, leaving folks buzzing at Hall 6. What RoamX Brings to the Table This ain't...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 172

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 481

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Korean 'Glocal' Districts Entice U.S. Tourists with Local Flavor

Updated Category News Views 97

Gwangju's Dongmyeong-dong is like the neighborhood artists and hipsters flock to in New York—except it’s got a Korean twist. Nestled in the Jeonnam region, this place is hot on American tourists' radar for its spicy mix of local culture, unique eats, and shops that scream individuality. It's becoming a magnet for folks who want to get a taste of Korean life but with a...

Continue Reading
Strathcona Resources Q3 2026: Dividends, Deals, and Growth

Updated Category News Views 202

Digging into Strathcona's Third Quarter Strathcona Resources (TSX: SCR) is strutting its stuff again, dropping a third-quarter report that reads like a playbook for solid energy sector performance. First off, let’s talk about that dividend bump. The company decided to sprinkle some cheer with a 7% increase in its quarterly dividend, now at $0.32 per share. Not exactly...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 147

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
O-I Glass Faces Class Action: Investor Implications

Updated Category News Views 46

O-I Glass in Hot Water Over Misleading Statements I'll tell you, nothing gets my goat quite like uncovering deceptive practices in the corporate world. It seems O-I Glass, Inc. (NYSE: OI), might have played a fast one with its shareholders. The company is staring down the barrel of a class action lawsuit from Schall, Brown & Schwartz LLP, alleging they weren't entirely...

Continue Reading
Onodrim Raises $300M to Propel EU Defence Future

Updated Category News Views 15

Onodrim Industries' Bold Bid to Reshape European Security Right out of the gate, Onodrim Industries is thundering onto the scene with a hefty $300 million Series A round to flex its muscles across Europe's defence and industrial sectors. This ain't your run-of-the-mill startup story. This is about flexing hard-earned capital to snap up established players and inject a...

Continue Reading
Tencent Cloud's Edge Platform Shines in New Gartner Report

Updated Category News Views 93

The Breakthrough in Edge Computing Everyone's talking about cloud this and cloud that, but Tencent Cloud is taking things a notch further with its EdgeOne platform. It's not just about storing your files in the sky; it's about having the fastest, most secure delivery possible. Gartner's latest report puts these guys right at the top in their Magic Quadrant for Edge...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 730

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding AMETEK's Short Interest and Investor Sentiment

Updated Category News Views 163

Understanding AMETEK's Short Interest AMETEK Inc (NYSE: AME) has recently seen a notable increase in short interest, with a 13.54% rise reported in its short percent of float. Currently, there are approximately 2.23 million shares sold short, equating to about 1.09% of all available regular shares. Given the current trading dynamics, traders would need about 1.43 days on...

Continue Reading
Hub Group Announces Quarterly Dividend for Investors

Updated Category News Views 126

Overview of Hub Group's Quarterly Dividend Announcement Hub Group, Inc. (NASDAQ: HUBG) has recently made headlines by declaring a quarterly cash dividend of $0.125 per share. This announcement comes directly from the company’s Board of Directors, showcasing their commitment to returning value to shareholders. The dividend reflects Hub Group's growth-focused capital...

Continue Reading
EfTEN United Property Fund's NAV Rises Slightly Amid Trends

Updated Category News Views 169

EfTEN United Property Fund's NAV Update The net asset value (NAV) of the EfTEN United Property Fund units reached 11.34 euros by the end of September, marking a modest month-on-month increase of 0.33%. This relatively small gain in NAV was influenced by the investment in EfTEN Real Estate Fund AS. The shares of this fund closed at 0.8% lower compared to the previous month...

Continue Reading
SDi Analyzes Key Trends in Lab Instrument Market for 2025

Updated Category News Views 162

Understanding the Laboratory Instruments Market Trends Strategic Directions International (SDi) has unveiled its pivotal report which dives deep into the global laboratory instrumentation market, showcasing insights about the competitive landscape. This analysis focuses on the performance of leading instrument manufacturers, providing a comprehensive understanding of...

Continue Reading
Davis Commodities Secures USD 30 Million for Growth Initiatives

Updated Category News Views 272

Davis Commodities Inc. Takes a Bold Step Forward Davis Commodities Limited (NASDAQ: DTCK) is initiating a transformative phase through the issuance of new shares valued at USD 30 million. This strategic decision marks a significant milestone for the company, aligning with its vision to enhance growth and expand operational capabilities. Advantages of Issuing New Shares...

Continue Reading